<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Offences — section 21.6 and serious risk</p><ul class="Section ProvisionList" id="234661"><li><p class="Subsection" id="1174211"><strong><a class="sectionLabel" id="s-31.4"><span class="sectionLabel">31.4</span></a></strong> <span class="lawlabel">(1)</span> A person who contravenes section 21.6, or who knowingly or recklessly causes a serious risk of injury to human health in contravening another provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174212"><span class="lawlabel">(a)</span> on conviction on indictment, to a fine the amount of which is at the discretion of the court or to imprisonment for a term not exceeding five years or to both; and</p></li><li><p class="Paragraph" id="1174213"><span class="lawlabel">(b)</span> on summary conviction, for a first offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both and, for a subsequent offence, to a fine not exceeding $1,000,000 or to imprisonment for a term not exceeding two years or to both.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clarification</p><p class="Subsection" id="1174214"><span class="lawlabel">(2)</span> For greater certainty, subsection (1) applies in respect of the following provisions of this Act:</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174216"><span class="lawlabel">(a)</span> section 3, if the contravention of that section involves a therapeutic product;</p></li><li><p class="Paragraph" id="1249414"><span class="lawlabel">(a.1)</span> section 3.1, if the contravention of that section involves a clinical trial that relates to a therapeutic product;</p></li><li><p class="Paragraph" id="1249415"><span class="lawlabel">(a.2)</span> section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to a therapeutic product;</p></li><li><p class="Paragraph" id="1174217"><span class="lawlabel">(b)</span> subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to a therapeutic product or a sample that is or relates to a therapeutic product;</p></li><li><p class="Paragraph" id="1174218"><span class="lawlabel">(c)</span> subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph" id="1174219"><span class="lawlabel">(d)</span> subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph" id="1174220"><span class="lawlabel">(e)</span> subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph" id="1174221"><span class="lawlabel">(f)</span> subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to a therapeutic product; and</p></li><li><p class="Paragraph" id="1174222"><span class="lawlabel">(g)</span> subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to a therapeutic product.</p></li></ul></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">2014, c. 24, ss. 9, 11</li><li class="HistoricalNoteSubItem">2019, c. 29, s. 175</li></ul></div>